Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery | Zendy

Don Poldermans | Zendy; Eric Boersma | Zendy; Jeroen J. Bax | Zendy; Ian R. Thomson | Zendy; Bernard P. Paelinck | Zendy; Louis L. van de Ven | Zendy; M. G. Scheffer | Zendy; Giuseppe Trocino | Zendy; Carlo Vigna | Zendy; Hubert F. Baars | Zendy; Hero van Urk | Zendy; J. Roelandt | Zendy

Open Access

Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery

Author(s) -

Don Poldermans,

Eric Boersma,

Jeroen J. Bax,

Ian R. Thomson,

Bernard P. Paelinck,

Louis L. van de Ven,

M. G. Scheffer,

Giuseppe Trocino,

Carlo Vigna,

Hubert F. Baars,

Hero van Urk,

J. Roelandt

Publication year - 2001

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1053/euhj.2000.2555

Subject(s) - medicine , bisoprolol , myocardial infarction , cardiology , coronary care unit , cardiac surgery , dobutamine , odds ratio , anesthesia , surgery , heart failure , hemodynamics

To assess the long-term cardioprotective effect of bisoprolol in a randomized high-risk population after successful major vascular surgery. High-risk patients were defined by the presence of one or more cardiac risk factor(s) and a dobutamine echocardiography test positive for ischaemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research